2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Chemoradiation: new trials by email Literature Review of Chemoradiation trials Research Report on Chemoradiation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing Ramipril to Prevent Memory Loss in People With Glioblastoma Ramipril - Glioblastoma, Radiotherapy; Complications | Phase 2 | Completed | Wake Forest University Health Sciences | 75 | 2019-03-25 | 2026-03-13 |
| Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01 SIB-IMRT, S-1 - Esophagus Cancer, Esophagogastric Junction Cancer | Phase 2 / Phase 3 | Completed | Chinese Academy of Medical Sciences | 350 | 2016-10-01 | 2020-07-21 |
Brain Neoplasms (1) · Cognitive Dysfunction (1) · Esophageal Neoplasms (1) · Glioblastoma (1)
Neoplasms (2) · Neoplasms by Site (2) · Astrocytoma (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Cognition Disorders (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Glioma (1) · Head and Neck Neoplasms (1) · Mental Disorders (1)
Ramipril (1) · S 1 (combination) (1)
Chinese Academy of Medical Sciences (1) · Wake Forest University Health Sciences (1)
China (1) · Guam (1) · United States (1)
Glenn Lesser, MD (1)
PMID 31036088, PMID 32983991, PMID 37195667
3UG1CA189824-04S1 (1)